5555-72-6Relevant articles and documents
INHIBITORS OF DUAL SPECIFICITY TYROSINE PHOSPHORYLATION REGULATED KINASE 1B
-
Page/Page column 152-153, (2021/04/10)
The present invention relates to compounds of formula (I), optionally in the form of a pharmaceutically acceptable salt, solvate, cocrystal, tautomer, racemate, enantiomer, or diastereomer or mixture thereof (I), in particular for use in the treatment, amelioration or prevention of cancer, Alzheimer, Parkinson, Down syndrome, Metabolic syndrome, Diabetes and/or osteoarthritis.
Reactions of N-benzyloxycarbamate derivatives with stabilized carbon nucleophiles: A new synthetic approach to polyhydroxamic acids and other hydroxamate-containing mixed ligand systems
Liu, Yuan,Jacobs, Hollie K.,Gopalan, Aravamudan S.
supporting information; experimental part, p. 782 - 788 (2009/07/11)
Hydroxamic acids are an important class of chelators of hard metal ions such as Fe(III), which have found applications in therapeutic, diagnostic, and separation chemistry. Hence, methods for their preparation and incorporation into various matrices are i